Voloridge Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.51M | Sell |
7,702
-54,600
| -88% | -$17.8M | 0.01% | 912 |
|
|
2025
Q1 | $16.8M | Buy |
62,302
+45,526
| +271% | +$12.3M | 0.06% | 411 |
|
|
2024
Q4 | $3.95M | Sell |
16,776
-177,471
| -91% | -$41.8M | 0.01% | 834 |
|
|
2024
Q3 | $53.4M | Buy |
194,247
+179,384
| +1,207% | +$49.3M | 0.19% | 147 |
|
|
2024
Q2 | $3.61M | Buy |
+14,863
| New | +$3.61M | 0.01% | 833 |
|
|
2023
Q4 | – | Sell |
-37,412
| Closed | -$6.63M | – | 1138 |
|
|
2023
Q3 | $6.63M | Sell |
37,412
-37,446
| -50% | -$6.63M | 0.03% | 572 |
|
|
2023
Q2 | $14.2M | Sell |
74,858
-66,530
| -47% | -$12.6M | 0.07% | 375 |
|
|
2023
Q1 | $28.3M | Sell |
141,388
-68,623
| -33% | -$13.7M | 0.14% | 214 |
|
|
2022
Q4 | $49.9M | Buy |
210,011
+138,481
| +194% | +$32.9M | 0.28% | 83 |
|
|
2022
Q3 | $14.3M | Buy |
+71,530
| New | +$14.3M | 0.08% | 343 |
|
|
2022
Q2 | – | Sell |
-29,380
| Closed | -$4.8M | – | 1408 |
|
|
2022
Q1 | $4.8M | Buy |
+29,380
| New | +$4.8M | 0.03% | 654 |
|
|
2021
Q4 | – | Sell |
-12,506
| Closed | -$2.36M | – | 1556 |
|
|
2021
Q3 | $2.36M | Buy |
+12,506
| New | +$2.36M | 0.02% | 996 |
|
|
2020
Q1 | – | Sell |
-38,410
| Closed | -$4.42M | – | 1065 |
|
|
2019
Q4 | $4.42M | Buy |
+38,410
| New | +$4.42M | 0.09% | 306 |
|
|
2018
Q2 | – | Sell |
-78,483
| Closed | -$9.35M | – | 398 |
|
|
2018
Q1 | $9.35M | Buy |
78,483
+65,470
| +503% | +$7.8M | 0.22% | 83 |
|
|
2017
Q4 | $1.65M | Sell |
13,013
-109,244
| -89% | -$13.9M | 0.04% | 337 |
|
|
2017
Q3 | $14.4M | Sell |
122,257
-14,405
| -11% | -$1.69M | 0.32% | 73 |
|
|
2017
Q2 | $10.9M | Buy |
+136,662
| New | +$10.9M | 0.27% | 101 |
|
|
2014
Q2 | – | Sell |
-8,898
| Closed | -$597K | – | 87 |
|
|
2014
Q1 | $597K | Buy |
+8,898
| New | +$597K | 0.08% | 63 |
|